Table 1.
Profiles of seven patients diagnosed with inflammatory pseudotumor of the liver
| Case No. | Sex | Age (yrs) | HBV infection | Clinical diagnosis | Liver biopsy | Preoperative AFP (ng/ml) | Preoperative PIVKA-II (mAU/ml) | Preoperative CA19-9 (ng/ml) | Extent of hepatic resection | Tumor size (cm) | Tumor number | Follow-up period (mos) | Survival status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 83 | No | Abscess, HIPT, ICC | HIPT | 2.5 | 27 | 15.7 | LL | 3.5 | 1 | 123 | Alive |
| 2 | M | 70 | No | HCC | ND | 3.2 | 17 | ND | RL | 5.0 | 1 | 94 | Alive |
| 3 | F | 56 | Yes | HCC, cHCC-CC | ND | 3.2 | 27 | 2 | LLS | 2.3 | 1 | 91 | Alive |
| 4 | M | 46 | Yes | HCC | No mass | 4.7 | 22 | ND | RAS | 0.7 | 1 | 89 | Alive |
| 5 | M | 60 | No | HCC | ND | 2.1 | 32 | 2.8 | RL | 5.5 | 1 | 79 | Alive |
| 6 | M | 61 | Yes | HCC | ND | 2 | 19 | 13.6 | LMS | 1.5 | 1 | 33 | Alive |
| 7 | M | 60 | Yes | Metastasis, HCC | ND | 4.8 | 36 | 10.4 | LLS | 2.5, 1.4 | 2 | 26 | Alive |
HBV, hepatitis B virus; HIPT, hepatic inflammatory pseudotumor; ICC, intrahepatic cholangiocarcinoma; HCC, hepatocellular carcinoma; cHCC-CC, combined hepatocellular carcinoma-cholangiocarcinoma; ND, not done; AFP, alpha-fetoprotein; PIVKA-II, protein induced by Vitamin K absence or antagonist-II; CA19-9, carbohydrate antigen 19-9; LL, left lobectomy; RL, right lobectomy; LLS, left lateral sectionectomy; RAS, right anterior sectionectomy; LMS, left medial sectionectomy